BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang JL, Liu M, Yang Q, Lin SY, Shan HB, Wang HY, Xu GL. Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer. World J Gastroenterol 2017; 23(14): 2575-2584 [PMID: 28465642 DOI: 10.3748/wjg.v23.i14.2575]
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2575.htm
Number Citing Articles
1
Marie Bridoux, Marie-Cécile Le Deley, Nicolas Bertrand, Nicolas Simon, Dienabou Sylla, Xavier Mirabel, Anthony Turpin. Effects of Proton Pump Inhibitors Intake During Chemoradiotherapy for Rectal Cancer: a Retrospective Cohort StudyJournal of Gastrointestinal Cancer 2023; 54(2): 545 doi: 10.1007/s12029-022-00825-z
2
Bihan Li, Ying Liu, Shilong Sun. Proton pump inhibitors display anti‐tumour potential in gliomaCell Proliferation 2023; 56(7) doi: 10.1111/cpr.13321
3
Soo Hee Jeong, Lara Molloy, Edmond Ang, Nuala Helsby. Re-thinking the possible interaction between proton pump inhibitors and capecitabineCancer Chemotherapy and Pharmacology 2022; 90(5): 381 doi: 10.1007/s00280-022-04473-9
4
Gaurav Taneja, Punniyakoti V. Thanikachalam, Satyendra K. Rajput. Dose and time-dependent toxicological impact of pantoprazole on vascular endothelium and renal tissueToxicology Letters 2020; 333: 97 doi: 10.1016/j.toxlet.2020.07.031
5
Mariafrancesca Scalise, Lara Console, Michele Galluccio, Lorena Pochini, Annamaria Tonazzi, Nicola Giangregorio, Cesare Indiveri. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for DrugsSLAS Discovery 2019; 24(9): 867 doi: 10.1177/2472555219856601
6
Márcia Fernanda Correia Jardim Paz, Marcus Vinícius Oliveira Barros de Alencar, Rodrigo Maciel Paulino de Lima, André Luiz Pinho Sobral, Glauto Tuquarre Melo do Nascimento, Cristiane Amaral dos Reis, Maria do Perpetuo Socorro de Sousa Coêlho, Maria Luísa Lima Barreto do Nascimento, Antonio Luiz Gomes Júnior, Kátia da Conceição Machado, Ag-Anne Pereira Melo de Menezes, Rosália Maria Torres de Lima, José Williams Gomes de Oliveira Filho, Ana Carolina Soares Dias, Antonielly Campinho dos Reis, Ana Maria Oliveira Ferreira da Mata, Sônia Alves Machado, Carlos Dimas de Carvalho Sousa, Felipe Cavalcanti Carneiro da Silva, Muhammad Torequl Islam, João Marcelo de Castro e Sousa, Ana Amélia de Carvalho Melo Cavalcante. Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and CancerOxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/3457890
7
Wan-Ying Lin, Shih-Syuan Wang, Yi-No Kang, Andrea S. Porpiglia, Yu Chang, Chin-Hsuan Huang, Ronak Bhimani, Eahab Abdul-Lattif, Muneeba Azmat, Tsu-Hsien Wang, Yu-Shiuan Lin, Yu-Cheng Chang, Kuan-Yu Chi. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1048980
8
Mengyuan Yang, Xian Zhong, Ying Yuan. Does Baking Soda Function as a Magic Bullet for Patients With Cancer? A Mini ReviewIntegrative Cancer Therapies 2020; 19 doi: 10.1177/1534735420922579
9
Grace G. Wong, Vincent Ha, Michael P. Chu, Deonne Dersch-Mills, Sunita Ghosh, Carole R. Chambers, Michael B. Sawyer. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal CancerClinical Colorectal Cancer 2019; 18(1): 72 doi: 10.1016/j.clcc.2018.11.001
10
Natalia Mastrogamvraki, Apostolos Zaravinos. Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancernpj Systems Biology and Applications 2020; 6(1) doi: 10.1038/s41540-020-00144-8
11
Anjali Menon, Aswin G. Abraham, Maria Mahfouz, Joseph J. Thachuthara, Nawaid Usmani, Heather Warkentin, Sunita Ghosh, Tirath Nijjar, Diane Severin, Keith Tankel, Kim Paulson, Karen Mulder, Wilson Roa, Kurian Joseph. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerAmerican Journal of Clinical Oncology 2021; 44(9): 487 doi: 10.1097/COC.0000000000000850
12
Ana Maria Oliveira Ferreira da Mata, Marcia Fernanda Correia Jardim Paz, Ag-Anne Pereira Melo de Menezes, Antonielly Campinho dos Reis, Bruna da Silva Souza, Carlos Dimas de Carvalho Sousa, Sônia Alves Machado, Thiago Soares Gondim Medeiros, Chandan Sarkar, Muhammad Torequl Islam, Javad Sharifi-Rad, Sevgi Durna Daştan, Mohammed M. Alshehri, João Marcelo de Castro e Sousa, Ana Amélia de Carvalho Melo Cavalcante. Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritisCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02563-5
13
Paulina Chmiel, Katarzyna Gęca, Adam Michalski, Martyna Kłosińska, Agnieszka Kaczyńska, Wojciech P. Polkowski, Zuzanna Pelc, Magdalena Skórzewska. Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System TumorsInternational Journal of Molecular Sciences 2023; 24(12): 9945 doi: 10.3390/ijms24129945
14
D. Viñal, N. Rodriguez-Salas, P. Perez-Wert, O. Higuera, I. Ghanem, J. Feliu. Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic reviewClinical and Translational Oncology 2020; 22(8): 1288 doi: 10.1007/s12094-019-02254-0
15
Xinchen Wang, Qing Liu, Óskar Ö. Halfdanarson, Helga Zoega, Omid Sadr-Azodi, Lars Engstrand, Katja Fall, Nele Brusselaers. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort studyBritish Journal of Cancer 2021; 125(6): 893 doi: 10.1038/s41416-021-01480-0
16
Magdalena Cybula, Magdalena Bieniasz. Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: Pre-clinical updatesOncotarget 2022; 13(1): 553 doi: 10.18632/oncotarget.28220
17
Romina Armando, Diego Mengual G�mez, Daniel Gomez. New drugs are not enough‑drug repositioning in oncology: An updateInternational Journal of Oncology 2020;  doi: 10.3892/ijo.2020.4966
18
Alexey Bogdanov, Andrey Bogdanov, Viacheslav Chubenko, Nikita Volkov, Fedor Moiseenko, Vladimir Moiseyenko. Tumor acidity: From hallmark of cancer to target of treatmentFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.979154
19
Chin-Chia Wu, Chuan-Yin Fang, Ben-Hui Yu, Chun-Ming Chang, Ta-Wen Hsu, Chung-Lin Hung, Shih-Kai Hung, Wen-Yen Chiou, Jui-Hsiu Tsai. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal CancerCancers 2023; 15(21): 5304 doi: 10.3390/cancers15215304
20
Alice Indini, Fausto Petrelli, Gianluca Tomasello, Erika Rijavec, Antonio Facciorusso, Francesco Grossi, Michele Ghidini. Impact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-AnalysisCancers 2020; 12(4): 998 doi: 10.3390/cancers12040998
21
Agastya Patel, Piotr Spychalski, Magdalena Antoszewska, Jaroslaw Regula, Jarek Kobiela. Proton pump inhibitors and colorectal cancer: A systematic reviewWorld Journal of Gastroenterology 2021; 27(44): 7716-7733 doi: 10.3748/wjg.v27.i44.7716